Abstract:Objective To investigate the characteristics of metabolic disorders among different phenotypes of women with polycystic ovary syndrome (PCOS). Methods A total of 251 consecutive untreated subfertile women with pre-diagnosed PCOS in outpatient clinics were enrolled. Laboratory examinations including OGTT,serum lipid profile and transvaginal sonography of ovary and uterus were carried out in all participants. Gonadal axis hormones were evaluated at early follicular phase. 34 eumenorrhea female were defined as healthy control (NC). Results (1 )Of these women,234 were diagnosed as PCOS according to the 2003 Rotterdam criteria. Among all the PCOS individuals,129 (55. 1%)cases met all 3 points of the Rotterdam criteria and were defined as fit 3 points group,while 105 (44. 9%)met 2 points and were defined as fit 2 points group. The simple polycystic ovary (PCO)group included 17 patients. Compared with NC group,PCOS women presented with insulin resistance,higher androgen level and more prevalence of metabolic disorders. Compared with the simple PCO group,the fit 2 points group had a significantly higher androgen,TC and rate of obesity (P<0. 05);the fit 3 points group showed a higher BMI,TC,LDL-C,androgen,LH/FSH radio and rate of obesity,and also had a significantly higher HOMA-IR and a lower Matsuda index (P<0. 05 ). Compared with the fit 2 points group,the fit 3 points group displayed a significantly higher BMI,rate of obesity,TC,LDL-C,androgen and LH/FSH radio,and also had a significantly higher FPG and HOMA-IR and a lower Matsuda index (P<0. 05). (2)Hyperandrogenism (HA)were found in 162 (69. 2%)of the 234 PCOS women. Compared with the non-HA group,the HA group had a significantly higher FPG,FIns and HOMA-IR and a lower Matsuda index (P<0. 05). (3)Of all the 234 women with PCOS,53. 8%were overweight or obese. The proportion of patients with elevated androgen levels,abnormal glucose metabolism and dyslipidemia increased in overweight/obese group than that in normal weight group (P<0. 05 ). Conclusion In women with PCOS,insulin resistance and metabolic abnormality are more prevalent in the subgroup met all 3 points of the diagnostic criteria than that in the other phenotype subgroups. Insulin resistance is deteriorated in PCOS women with HA,and reproductive endocrine and metabolic abnormalities are worsen in PCOS women with overweight or obesity.

Serum High-Sensitivity C-reactive Protein and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome

Serum C-reactive Protein and Its Relationship with Clinic Factors in Patients with Polycystic Ovary Syndrome

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study

Elevated C-reactive Protein and Monocyte Chemoattractant Protein-1 in Patients with Polycystic Ovary Syndrome

[Clinical Features of the Metabolic Syndrome in Patients with Polycystic Ovary Syndrome].

To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS

Serum Procalcitonin and Proinflammatory markers in Polycystic Ovary Syndrome

Association of vascular and inflammatory markers with metabolic disorders in women with polycystic ovary syndrome

Prevalence, characteristics and predictors of the metabolic syndrome in women with polycystic ovary syndrome

Serum Heat Shock Protein 70 Concentration In Relation To Polycystic Ovary Syndrome In A Non-Obese Chinese Population

Can Serum Apolipoprotein C-I Demonstrate Metabolic Abnormality Early in Women with Polycystic Ovary Syndrome?

The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome

Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry

High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)

Alteration of Sera Leptin and Relevant Factors in Patients with Polycystic Ovary Syndrome

Status of Homocysteine in Polycystic Ovary Syndrome (PCOS)

Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome

Serum Levels of Leptin and Homocysteine in Women with Polycystic Ovary Syndrome and Its Relationship to Endocrine, Clinical and Metabolic Parameters

Characteristics of metabolic disorders in different phenotype subgroups of patients with polycystic ovary syndrome

[Monocyte Chemoattractant Protein-1 and Its Correlation with Lipoprotein in Polycystic Ovary Syndrome].

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome